Kemp Dolliver
Stock Analyst at Brookline Capital
(0.64)
# 4,122
Out of 5,147 analysts
19
Total ratings
38.46%
Success rate
-13.96%
Average return
Main Sectors:
Stocks Rated by Kemp Dolliver
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LSTA Lisata Therapeutics | Downgrades: Hold | n/a | $4.10 | - | 2 | Jan 21, 2026 | |
| RNTX Rein Therapeutics | Downgrades: Hold | n/a | $1.14 | - | 2 | Jan 21, 2026 | |
| VRCA Verrica Pharmaceuticals | Upgrades: Buy | $17 | $5.47 | +210.79% | 3 | Dec 18, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $18 | $4.99 | +260.72% | 1 | Jul 21, 2025 | |
| IBIO iBio, Inc. | Initiates: Buy | $3.6 | $2.82 | +27.66% | 1 | Jul 22, 2024 | |
| DARE Daré Bioscience | Upgrades: Buy | $36 | $1.70 | +2,017.65% | 2 | May 15, 2024 | |
| OTLK Outlook Therapeutics | Upgrades: Buy | $31 | $0.42 | +7,363.75% | 1 | Jan 25, 2024 | |
| LNTH Lantheus Holdings | Initiates: Buy | $100 | $74.91 | +33.49% | 1 | Nov 30, 2023 | |
| EDSA Edesa Biotech | Maintains: Buy | $57 | $2.20 | +2,490.91% | 2 | Oct 12, 2023 | |
| GNLX Genelux | Initiates: Hold | $25 | $2.98 | +738.93% | 1 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $7.58 | +147.36% | 1 | Jan 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $8 | $0.75 | +966.67% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5.65 | $0.58 | +877.85% | 1 | Feb 2, 2022 |
Lisata Therapeutics
Jan 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $4.10
Upside: -
Rein Therapeutics
Jan 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $1.14
Upside: -
Verrica Pharmaceuticals
Dec 18, 2025
Upgrades: Buy
Price Target: $17
Current: $5.47
Upside: +210.79%
Radiopharm Theranostics
Jul 21, 2025
Initiates: Buy
Price Target: $18
Current: $4.99
Upside: +260.72%
iBio, Inc.
Jul 22, 2024
Initiates: Buy
Price Target: $3.6
Current: $2.82
Upside: +27.66%
Daré Bioscience
May 15, 2024
Upgrades: Buy
Price Target: $36
Current: $1.70
Upside: +2,017.65%
Outlook Therapeutics
Jan 25, 2024
Upgrades: Buy
Price Target: $31
Current: $0.42
Upside: +7,363.75%
Lantheus Holdings
Nov 30, 2023
Initiates: Buy
Price Target: $100
Current: $74.91
Upside: +33.49%
Edesa Biotech
Oct 12, 2023
Maintains: Buy
Price Target: $57
Current: $2.20
Upside: +2,490.91%
Genelux
May 18, 2023
Initiates: Hold
Price Target: $25
Current: $2.98
Upside: +738.93%
Jan 13, 2023
Initiates: Buy
Price Target: $19
Current: $7.58
Upside: +147.36%
Oct 21, 2022
Assumes: Buy
Price Target: $8
Current: $0.75
Upside: +966.67%
Feb 2, 2022
Initiates: Buy
Price Target: $5.65
Current: $0.58
Upside: +877.85%